ADC Therapeutics SA (ADCT) Files Form 13G on April 6

ADC Therapeutics SA (ADCT) submitted Form 13G on April 6, which is typically used to report beneficial ownership of securities by institutional investors. The filing reveals ownership stakes that may indicate significant investor interest or changes in equity positions. Such filings can influence market perception and trading volumes. Monitoring these filings is crucial for understanding investor sentiment towards ADCT.